Cryoablation Combined With Camrelizumab and Apatinib for Multiprimary Lung Cancer
Clinical trial NCT04201990 · UNKNOWN
Trial details
- NCT number
- NCT04201990
- Sponsor
- ShiYue Li
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2021-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.